FibroBiologics Secures US Patent For Therapeutic Use Of Fibroblasts For Use In Wound Healing
Newly Issued Patent Covers Topical Administration of 3D Spheroid Fibroblasts and Fibroblast-Derived Materials to Treat and Accelerate the Healing of WoundsHOUSTON, Sept. 3, 2026 /PRNewswire/ -- FibroBiologics, Inc.
FibroBiologics got official permission from the U.S. government to use special cells to help wounds heal faster. This shows the company has a real invention that's legally protected, which is one step toward helping patients.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.